Viewing Study NCT04526834

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-03-02 @ 6:24 PM
Study NCT ID: NCT04526834
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-04-20
First Post: 2020-08-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma
Sponsor: Tessa Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anaplastic Large Cell Lymphoma View
None Peripheral T Cell Lymphoma View
None Extranodal NK/T-cell Lymphoma View
None Diffuse Large B Cell Lymphoma View
None Primary Mediastinal Large B-Cell Lymphoma (PMBCL) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CD30, r/r NHL, DLBCL, ALCL, ENKTCL, PMBCL, PTCL, adult View